By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Unable to reach a licensing deal with a lender, Rosetta Genomics will not receive a $1.25 million payment, the company disclosed in a document filed with the US Securities and Exchange Commission today.

Rosetta and the unnamed lender had agreed to negotiate for the licensing deal as part of a $1.75 million private placement raise that Rosetta announced in late January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.